Recombinant human lactoferrin: A valuable protein for pharmaceutical products and functional foods

Biotechnology Advances

Volumn 28, Issue 6, 2010, Pages 831-838

  Conesa, Celia ^a   Calvo, Miguel ^a   Sánchez, Lourdes ^a  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Anti bacterial activity; Aspergillus awamori; Functional foods; Human lactoferrin; Iron binding; Pharmaceutical products; Recombinant lactoferrin; Rice; Transgenic cows

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ASPERGILLUS AWAMORI; FUNCTIONAL FOODS; HUMAN LACTOFERRIN; IRON-BINDING; LACTOFERRIN; PHARMACEUTICAL PRODUCTS; RICE; TRANSGENICS;

BACTERIOLOGY;

BODY FLUIDS;

LACTOFERRIN; RECOMBINANT PROTEIN;

ANTIMICROBIAL ACTIVITY; BIOACTIVITY; DRUG; GENETICALLY MODIFIED ORGANISM; IRON; METAL BINDING; MILK; NUTRITIONAL REQUIREMENT; PROTEIN; RECOMBINATION; RICE; YEAST;

ANIMAL; CHEMISTRY; FUNCTIONAL FOOD; FUNGUS; HUMAN; METABOLISM; PLANT; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; FUNCTIONAL FOOD; FUNGI; HUMANS; LACTOFERRIN; PLANTS; RECOMBINANT PROTEINS;

ASPERGILLUS AWAMORI; BACTERIA (MICROORGANISMS); BOS;

EID: 77957019333     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2010.07.002     Document Type: Review

References (102)

1. Aisen P., Leibman A. Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 1972, 257:314-323.
2. Andersen J.H. Technology evaluation: rh lactoferrin, Agennix. Curr Opin Mol Ther 2004, 6:344-349.
3. Anderson B.F., Baker H.M., Dodson E.J., Norris G.E., Rumball S.V., Waters J.M., et al. Structure of human lactoferrin at 3.2-Å resolution. Proc Natl Acad Sci USA 1987, 84:1769-1773.
4. Anderson B.F., Baker H.M., Norris G.E., Rice D.W., Baker E.N. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 Å resolution. J Mol Biol 1989, 209:711-734.
5. Anderson B.F., Baker H.M., Norris G.E., Rumball S.V., Baker E.N. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature 1990, 344:784-787.
6. Appel M.J., van Veen H.A., Vietsch H., Salaheddine M., Nuijens J.H., Ziere B., et al. Sub-chronic (13-week) oral toxicity study in rats with recombinant human lactoferrin produced in the milk of transgenic cows. Food Chem Toxicol 2006, 44:964-973.
7. Ashida K., Sasaki H., Suzuki Y.A., Lönnerdal B. Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 2004, 17:311-315.
8. Baker E.N., Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 2005, 62:2531-2539.
9. Baker E.N., Baker H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 2009, 91:3-10.
10. Baker E.N., Anderson B.F., Baker H.M., Haridas M., Jameson G.B., Norris G.E., et al. Structure, function and flexibility of human lactoferrin. Int J Biol Macromol 1991, 13:122-129.
11. Bethell D.R., Huang J. Recombinant human lactoferrin treatment for global health issues: iron deficiency and acute diarrhea. Biometals 2004, 17:337-342.
12. Brock J.H. The physiology of lactoferrin. Biochem Cell Biol 2002, 80:1-6.
13. Cerven D., Degeorge G., Bethell D. 28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats. Regul Toxicol Pharmacol 2008, 51:162-167.
14. Cerven D., Degeorge G., Bethell D. 28-day repeated dose oral toxicity of recombinant human holo-lactoferrin in rats. Regul Toxicol Pharmacol 2008, 52:174-179.
15. Choi B.K., Actor J.K., Rios S., d'Anjou M., Stadheim T.A., Warburton S., et al. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj J 2008, 25:581-593.
16. Chong D.K., Langridge W.H. Expression of full-length bioactive antimicrobial human lactoferrin in potato plants. Transgenic Res 2000, 9:71-78.
17. Conesa C., Sánchez L., Pérez M.D., Calvo M. A calorimetric study of thermal denaturation of recombinant human lactoferrin from rice. J Agric Food Chem 2007, 55:4848-4853.
18. Conesa C., Rota M.C., Pérez M.D., Calvo M., Sánchez L. Antimicrobial activity of recombinant human lactoferrin from Aspergillus awamori, human milk lactoferrin and their hydrolysates. Eur Food Res Technol 2008, 228:205-211.
19. Conesa C., Pocoví C., Pérez M.D., Calvo M., Sánchez L. Recombinant human lactoferrin and iron transport across Caco-2 monolayers: effect of heat treatment on the binding to cells. J Agric Food Chem 2008, 56:2831-2837.
20. Conesa C., Rota C., Castillo E., Pérez M.D., Calvo M., Sánchez L. Antibacterial activity of recombinant human lactoferrin from rice: effect of heat treatment. Biosci Biotechnol Biochem 2009, 73:1301-1307.
21. Conesa C., Pocoví C., Pérez M.D., Calvo M., Sánchez L. Transport of iron bound to recombinant human lactoferrin from rice and iron citrate across Caco-2 cell monolayers. Biosci Biotechnol Biochem 2009, 73:2615-2620.
22. Drakakaki G., Christou P., Stöger E. Constitutive expression of soybean ferritin cDNA in transgenic wheat and rice results in increased iron levels in vegetative tissues but not in seeds. Transgenic Res 2000, 9:445-452.
23. Engelmayer J., Blezinger P., Varadhachary A. Talactoferrin stimulates wound healing with modulation of inflammation. J Surg Res 2008, 149:278-286.
24. Farnaud S., Evans R.W. Lactoferrin: the conductor of the immunological system?. New research on immunology 2005, 47-76. Nova Science Publishers, New York. B.A. Veskler (Ed.).
25. Fujiyama K., Sakai Y., Misaki R., Yanagihara I., Honda T., Anzai H., et al. N-linked glycan structures of human lactoferrin produced by transgenic rice. Biosci Biotechnol Biochem 2004, 68:2565-2570.
26. Goto F., Yoshihara T., Shigemoto N., Toki S., Takaiwa F. Iron fortification of rice seed by the soybean ferritin gene. Nat Biotechnol 1999, 17:282-286.
27. Groves M.L. The isolation of a red protein from milk. J Am Chem Soc 1960, 82:3345-3350.
28. Han Z.S., Li Q.W., Zhang Z.Y., Xiao B., Gao D.W., Wu S.Y., et al. High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors. Protein Expr Purif 2007, 53:225-231.
29. Hayes T.G., Falchook G.F., Varadhachary G.R., Smith D.P., Davis L.D., Dhingra H.M., et al. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest New Drugs 2006, 24:233-240.
30. Huang N., Simmons C.R., Rodriguez R.L. Codon usage patterns in plant genes. J CAASS 1990, 1:73-86.
31. Huang J., Wu L., Yalda D., Adkins Y., Kelleher S.L., Crane M., et al. Expression of functional recombinant human lysozyme in transgenic rice cell culture. Transgenic Res 2002, 11:229-239.
32. Huang N., Bethell D., Card C., Cornish J., Marchbank T., Wyatt D., et al. Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth in vitro. Cell Dev Biol Anim 2008, 44:464-471.
33. Humphrey B.D., Huang N., Klasing K.C. Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J Nutr 2002, 132:1214-1218.
34. Hwang S.A., Wilk K., Kruzel M.L., Actor J.K. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine 2009, 27:3026-3034.
35. Hyvönen P., Suojala L., Haaranen J., von Wright A., Pyörälä S. Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation. Biotechnol J 2006, 1:410-412.
36. Hyvönen P., Suojala L., Orro T., Haaranen J., Simola O., Røntved C., et al. Transgenic cows that produce recombinant human lactoferrin in milk are not protected from experimental Escherichia coli intramammary infection. Infect Immun 2006, 74:6206-6212.
37. Jo S.H., Kwon S.Y., Park D.S., Yang K.S., Kim J.W., Lee K.T., et al. High-yield production of functional human lactoferrin in transgenic cell cultures of Siberian ginseng (Acanthopanax senticosus). Biotechnol Bioprocess Eng 2006, 11:442-448.
38. Johanson B. Isolation of an iron-containing red protein from human milk. Acta Chem Scand 1960, 14:510-513.
39. Jonasch E., Stadler W.M., Bukowski R.M., Hayes T.G., Varadhachary A., Malik R., et al. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer 2008, 113:72-77.
40. Kamenarova K., Gecheff K., Stoyanova M., Muhovski Y., Anzai H., Atanassov A. Production of recombinant human lactoferin in transgenic barley. Biotechnol Biotechnol Equip 2007, 21:18-27.
41. Kawakami H., Lönnerdal B. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am J Physiol 1991, 261:G841-G846.
42. Kwon S.Y., Jo S.H., Lee O.S., Choi S.M., Kwak S.S., Lee H.S. Transgenic ginseng cell lines that produce high levels of a human lactoferrin. Planta Med 2003, 69:1005-1008.
43. Lee S.H., de Boer H.A. Production of biomedical proteins in the milk of transgenic dairy-cows-the state-of-the-art. J Control Release 1994, 29:213-221.
44. Lee T.J., Coyne D.P., Clemente T.E., Mitra A. Partial resistance to bacterial wilt in transgenic tomato plants expressing antibacterial lactoferrin gene. J Am Soc Hortic Sci 2002, 127:158-164.
45. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica 1995, 80:252-267.
46. Li L., Shen W., Min L.J., Dong H.S., Sun Y.J., Pan Q.J. Human lactoferrin transgenic rabbits produced efficiently using dimethylsulfoxide-sperm-mediated gene transfer. Reprod Fertil Dev 2006, 18:689-695.
47. Liang Q., Richardson T. Expression and characterization of human lactoferrin in yeast Saccharomyces cerevisiae. J Agric Food Chem 1993, 41:1800-1807.
48. Liu Z.L., Zhao C.J., Fan B.L., Dai Y.P., Zhao Z.H., Wang L.L., et al. Variable expression of human lactoferrin gene in mice milk driven by its 90KB upstream flanking sequences. Anim Biotechnol 2004, 15:21-31.
49. Liu T., Zhang Y.Z., Wu X.F. High level expression of functionally active human lactoferrin in silkworm larvae. J Biotechnol 2005, 118:246-256.
50. Liu T., Zhang Y.Z., Wu X.F. Recombinant functional human lactoferrin expressed in baculovirus system. Acta Biochim Biophys Sin (Shanghai) 2006, 38:201-206.
51. Lönnerdal B. Expression of human milk proteins in plants. J Am Coll Nutr 2002, 21:218S-221S.
52. Lyons T.E., Miller M.S., Serena T., Sheehan P., Lavery L., Kirsner R.S., et al. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg 2007, 193:49-54.
53. Mata L., Sánchez L., Headon D.R., Calvo M. Thermal denaturation of human lactoferrin and its effect on the ability to bind iron. J Agric Food Chem 1998, 46:3964-3970.
54. Mazurier J., Metz-Boutigue M.H., Jollès J., Spik G., Montreuil J., Jollès P. Human lactotransferrin: molecular, functional and evolutionary comparisons with human serum transferrin and hen ovotransferrin. Experientia 1983, 39:135-141.
55. Min S.R., Woo J.W., Jeong W.J., Han S.K., Lee Y.B., Liu J.R. Production of human lactoferrin in transgenic cell suspension cultures of sweet potato. Biol Plant 2006, 50:131-134.
56. Mitra A., Zhang Z. Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein(s). Plant Physiol 1994, 106:977-981.
57. Moguilevsky N., Retegui L.A., Masson P.L. Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem J 1985, 229:353-359.
58. Montreuil J., Mullet S. Isolation of lactosiderophilin from human milk. C R Hebd Seances Acad Sci 1960, 250:1736-1737.
59. Nakamura I., Watanabe A., Tsunemitsu H., Lee N.Y., Kumura H., Shimazaki K.I., et al. Production of recombinant bovine lactoferrin N-lobe in insect cells and its antimicrobial activity. Protein Expr Purif 2001, 21:424-431.
60. Nakayama K., Otsuki K., Yakuwa K., Hasegawa A., Sawada M., Mitsukawa K., et al. Recombinant human lactoferrin inhibits matrix metalloproteinase (MMP-2, MMP-3, and MMP-9) activity in a rabbit preterm delivery model. J Obstet Gynaecol Res 2008, 34:931-934.
61. Nandi S., Suzuki Y.A., Huang J., Yalda D., Pham P., Wu L., et al. Expression of human lactoferrin in transgenic rice grains for the application in infant formula. Plant Sci 2002, 163:713-722.
62. Nandi S., Yalda D., Lu S., Nikolov Z., Misaki R., Fujiyama K., et al. Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain. Transgenic Res 2005, 14:237-249.
63. Nuijens J.H., van Berkel P.H., Geerts M.E., Hartevelt P.P., de Boer H.A., van Veen H.A., et al. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice. J Biol Chem 1997, 272:8802-8807.
64. Parikh P.M., Wang Y.Y., Ranade A.A., Vaid A.K., Advani S.H., Raghunadharao D., et al. Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial. J Thorac Oncol 2007, 2:S360.
65. Platenburg G.J., Kootwijk E.P., Kooiman P.M., Woloshuk S.L., Nuijens J.H., Krimpenfort P.J., et al. Expression of human lactoferrin in milk of transgenic mice. Transgenic Res 1994, 3:99-108.
66. Rachmawati D., Mori T., Hosaka T., Takaiwa F., Inoue E., Anzai H. Production and characterization of recombinant human lactoferrin in transgenic javanica rice. Breed Sci 2005, 55:213-222.
67. Salmon V., Legrand D., Georges B., Slomianny M.C., Coddeville B., Spik G. Characterization of human lactoferrin produced in the baculovirus expression system. Protein Expr Purif 1997, 9:203-210.
68. Salmon V., Legrand D., Slomianny M.C., el Yazidi I., Spik G., Gruber V., et al. Production of human lactoferrin in transgenic tobacco plants. Protein Expr Purif 1998, 13:127-135.
69. Samyn-Petit B., Gruber V., Flahaut C., Wajda-Dubos J.P., Farrer S., Pons A., et al. N-glycosylation potential of maize: the human lactoferrin used as a model. Glycoconj J 2001, 18:519-527.
70. Samyn-Petit B., Wajda Dubos J.P., Chirat F., Coddeville B., Demaizieres G., Farrer S., et al. Comparative analysis of the site-specific N-glycosylation of human lactoferrin produced in maize and tobacco plants. Eur J Biochem 2003, 270:3235-3242.
71. Schafer K.H. Elektrophoretische untersuchungen zum milcheiwwissproblem. Monatsschr Kinderheilkd 1951, 99:69-71.
72. Sørensen M., Sørensen S.P.L. The proteins in whey. Compt Rendus Laboratoire Carlsberg 1939, 23:55-99.
73. Spik G., Strecker G., Fournet B., Bouquelet S., Montreuil J., Dorland L., et al. Primary structure of the glycans from human lactotransferrin. Eur J Biochem 1982, 121:413-419.
74. Stoger E., Sack M., Nicholson L., Fischer R., Christou P. Recent progress in plantibody technology. Curr Pharm Des 2005, 11:2439-2457.
75. Stowell K.M., Rado T.A., Funk W.D., Tweedie J.W. Expression of cloned human lactoferrin in baby-hamster kidney cells. Biochem J 1991, 276:349-355.
76. Sun X.L., Baker H.M., Shewry S.C., Jameson G.B., Baker E.N. Structure of recombinant human lactoferrin expressed in Aspergillus awamori. Acta Cryst 1999, D55:403-407.
77. Suzuki Y.A., Kelleher S.L., Yalda D., Wu L., Huang J., Huang N., et al. Expression, characterization, and biologic activity of recombinant human lactoferrin in rice. J Pediatr Gastroenterol Nutr 2003, 36:190-199.
78. Swarts J.C., Swarts P.J., Baker E.N., Baker H.M. Spectroscopic studies on metal complexes of Aspergillus awamori-derived recombinant human lactoferrin. Inorganica Chim Acta 2000, 298:187-194.
79. Terashima M., Murai Y., Kawamura M., Nakanishi S., Stoltz T., Chen L., et al. Production of functional human alpha(1)-antitrypsin by plant cell culture. Appl Microbiol Biotechnol 1999, 52:516-523.
80. Thomassen E.A., van Veen H.A., van Berkel P.H., Nuijens J.H., Abrahams J.P. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res 2005, 14:397-405.
81. Tomita M., Wakabayashi H., Shin K., Yamauchi K., Yaeshima T., Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 2009, 91:52-57.
82. Tutykhina I.L., Bezborodova O.A., Shmarov M.M., Logunov D.Y., Neugodova G.L., Nemtsova E.R., et al. Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristics. Protein Expr Purif 2009, 65:100-107.
83. Tutykhina I.L., Bezborodova O.A., Verkhovskaia L.V., Shmarov M.M., Logunov DIu, Nemtsova E.R., et al. Recombinant pseudoadenovirus nanostructure with human lactoferrin gene: production and study of lactoferrin expression and properties in vivo usage of the construction. Mol Gen Mikrobiol Virusol 2009, 1:27-31.
84. Twyman R.M., Stoger E., Schillberg S., Christou P., Fischer R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol 2003, 21:570-578.
85. van Berkel P.H.C., Welling M.M., Geerts M., van Veen H.A., Ravensbergen B., Salaheddine M., et al. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol 2002, 20:484-487.
86. Varadhachary A., Wolf J.S., Petrak K., O'Malley B.W., Spadaro M., Curcio C., et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 2004, 111:398-403.
87. Venkatesh M.P., Rong L. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J Med Microbiol 2008, 57:1113-1121.
88. Vikram P, Prem Kumar R, Singh N, Kumar J, Ethayathulla AS, Sharma S, Kaur P, Singh T. Structure of human diferric lactoferrin at 2.5 Å resolution using crystals grown at pH 6.5. Protein Data Bank entry 1SQY. in press.
89. Wakabayashi H., Yamauchi K., Takase M. Lactoferrin research, technology and applications. Int Dairy J 2006, 16:1241-1251.
90. Wang Y., Raghunadharao D., Raman G., Doval D., Advani S., Julka P., et al. Adding oral talactoferrin to first-line NSCLC chemotherapy safely enhanced efficacy in a randomized trial. J Clin Oncol 2006, 24:387S.
91. Ward P.P., Lo J.Y., Duke M., May G.S., Headon D.R., Conneely O.M. Production of biologically active recombinant human lactoferrin in Aspergillus oryzae. Biotechnology (N Y) 1992, 10:784-789.
92. Ward P.P., May G.S., Headon D.R., Conneely O.M. An inducible expression system for the production of human lactoferrin in Aspergillus nidulans. Gene 1992, 122:219-223.
93. Ward P.P., Piddington C.S., Cunningham G.A., Zhou X., Wyatt R.D., Conneely O.M. A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology (N Y) 1995, 13:498-503.
94. Ward P.P., Zhou X., Conneely O.M. Cooperative interactions between the amino- and carboxyl-terminal lobes contribute to the unique iron-binding stability of lactoferrin. J Biol Chem 1996, 271:12790-12794.
95. Ward P.P., Paz E., Conneely O.M. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005, 62:2540-2548.
96. Weinberg E.D. The therapeutic potential of lactoferrin. Expert Opin Investig Drugs 2003, 12:841-851.
97. Yakuwa K., Otsuki K., Nakayama K., Hasegawa A., Sawada M., Mitsukawa K., et al. Recombinant human lactoferrin has a potential to suppress uterine cervical ripening in preterm delivery in animal model. Arch Gynecol Obstet 2007, 275:331-334.
98. Yang P., Wang J., Gong G., Sun X., Zhang R., Du Z., et al. Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin. PLoS ONE 2008, 3:e3453.
99. Zavaleta N., Figueroa D., Rivera J., Sánchez J., Alfaro S., Lönnerdal B. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr 2007, 44:258-264.
100. Zhang D.B., Jiang Y.L., Wu X.F., Hong M.M. Expression of human lactoferrin cDNA in insect cells. Acta Biochim Biophys Sin (Shanghai) 1998, 30:575-578.
101. Zhang J., Li L., Cai Y.F., Xu X.J., Chen J., Wu Y.B., et al. Expression of active recombinant human lactoferrin in the milk of transgenic goats. Protein Expr Purif 2008, 57:127-135.
102. Zhao C., Liu Z., Fan B., Dai Y., Wang L., Zheng M., et al. Differential glycosylation of rhLf expressed in the mammary gland of transgenic mice. Anim Biotechnol 2006, 17:13-20.